BNP Paribas Financial Markets
BLFS icon

BNP Paribas Financial Markets’s BioLife Solutions BLFS Stock Holding History

BNP Paribas Financial Markets’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Buy
132,891
+43,791
+49% +$1.02M ﹤0.01% 2323
2026
Q1 		$1.7M Buy
89,100
+70,140
+370% +$1.55M ﹤0.01% 2770
2025
Q4 		$458K Sell
18,960
-6,673
-26% -$175K ﹤0.01% 3620
2025
Q3 		$654K Buy
25,633
+6,878
+37% +$163K ﹤0.01% 3411
2025
Q2 		$404K Buy
18,755
+6,997
+60% +$158K ﹤0.01% 3457
2025
Q1 		$269K Sell
11,758
-2,252
-16% -$59.3K ﹤0.01% 3544
2024
Q4 		$364K Sell
14,010
-6,835
-33% -$170K ﹤0.01% 3498
2024
Q3 		$522K Sell
20,845
-16,880
-45% -$399K ﹤0.01% 2837
2024
Q2 		$808K Sell
37,725
-15,790
-30% -$306K ﹤0.01% 2402
2024
Q1 		$993K Buy
53,515
+38,201
+249% +$668K ﹤0.01% 2508
2023
Q4 		$249K Buy
15,314
+513
+3% +$6.54K ﹤0.01% 3121
2023
Q3 		$204K Buy
14,801
+5,452
+58% +$85.9K ﹤0.01% 3079
2023
Q2 		$207K Sell
9,349
-3,100
-25% -$65.3K ﹤0.01% 3000
2023
Q1 		$271K Buy
12,449
+2,884
+30% +$64.9K ﹤0.01% 3024
2022
Q4 		$174K Sell
9,565
-3,592
-27% -$74.2K ﹤0.01% 3045
2022
Q3 		$299K Buy
13,157
+2,296
+21% +$49.1K ﹤0.01% 3297
2022
Q2 		$150K Sell
10,861
-8,819
-45% -$129K ﹤0.01% 3205
2022
Q1 		$447K Sell
19,680
-51,924
-73% -$1.37M ﹤0.01% 2800
2021
Q4 		$2.67M Buy
71,604
+44,325
+162% +$1.9M ﹤0.01% 1796
2021
Q3 		$1.15M Buy
27,279
+26,290
+2,658% +$1.27M ﹤0.01% 2275
2021
Q2 		$44K Sell
989
-919
-48% -$32.4K ﹤0.01% 3302
2021
Q1 		$68.7K Sell
1,908
-698
-27% -$27.6K ﹤0.01% 3504
2020
Q4 		$104K Sell
2,606
-384
-13% -$13.1K ﹤0.01% 3189
2020
Q3 		$86.5K Buy
2,990
+2,785
+1,359% +$60.1K ﹤0.01% 3198
2020
Q2 		$3.35K Sell
205
-1,997
-91% -$27.5K ﹤0.01% 4127
2020
Q1 		$20.9K Buy
2,202
+1,248
+131% +$17.1K ﹤0.01% 3900
2019
Q4 		$15.4K Buy
954
+629
+194% +$10.2K ﹤0.01% 4061
2019
Q3 		$5.4K Buy
325
+308
+1,812% +$5.78K ﹤0.01% 4259
2019
Q2 		$288 Buy
+17
New +$296 ﹤0.01% 4441
2018
Q3 		– Sell
-70,000
Closed -$799K – 4442
2018
Q2 		$799K Buy
+70,000
New +$637K ﹤0.01% 1820

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Financial Markets's BLFS Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its BioLife Solutions (BLFS) stake by 49% in Q2 2026, buying an estimated $1.02M and bringing the position to 132,891 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

BNP Paribas Financial Markets first reported a position in BLFS in Q2 2018 and has held it in 30 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • BNP Paribas Financial Markets held 132,891 shares of BioLife Solutions worth $3.75M as of Q2 2026.
  • BNP Paribas Financial Markets bought 43,791 BioLife Solutions shares in Q2 2026, an estimated $1.02M.
  • BioLife Solutions made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2323 holding.
  • BNP Paribas Financial Markets first reported a position in BioLife Solutions in Q2 2018 and has held it in 30 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.